Cytotoxic and genotoxic effects of β-(triphenylphosphonio)ethyl carboxylate and of N,N′-bis(dihexylphosphinoylmethyl)-1,4- diaminocyclohexane

Medical Science Monitor

Volumn 10, Issue 8, 2004, Pages

  Ilinskaya, Olga ^a   Zelenikhin, Pavel ^a   Kolpakov, Alexey ^a   Karamova, Nazira ^a   Margulis, Anna ^a  

^a KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

(triphenylphosphonio)ethyl carboxylate; Cytotoxicity; Metabolic activation; Mutagenicity; N,N bis(dihexylphosphinoylmethyl) 1,4 diaminocyclohexane; Organophosphorous compounds; SOS response

Indexed keywords

BETA (TRIPHENYLPHOSPHONIO)ETHYL CARBOXYLATE; DNA; LYASE; MICROSOME ENZYME; N,N' BIS(DIHEXYLPHOSPHINOYLMETHYL) 1,4 DIAMINOCYCLOHEXANE; ORGANOPHOSPHORUS COMPOUND; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL RESPIRATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENOTOXICITY; MOUSE; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL DIVISION; CYCLOHEXYLAMINES; MICE; MUTAGENICITY TESTS; MUTAGENS; NIH 3T3 CELLS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHINIC ACIDS; PROPIONATES; SALMONELLA TYPHIMURIUM;

EID: 4444270523     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Veronesi B, Ehrich M, Blusztajn JK et al: Cell culture models of interspecies selectivity to organophosphorous insecticides, Neurotoxicology, 1997; 18: 283-97
2. Kim AD, Baker AS, Dunaway-Mariano D et al: The 2-aminoethylphosphonate- specific transaminase of the 2-aminoethylphosphonate degradation pathway. J Bacteriol. 2002; 184: 4134-40
3. Chen CCH, Zhang H, Kim AD et al: Degradation pathway of the phosphonate ciliatine: crystal structure of 2-aminoethylphsphonate transaminase, Biochemistry, 2002; 41: 13162-69
4. Krzysko-Lupicka T, Strof W, Kubs K et al: The ability of soil-borne fungi to degrade organophosphonate carbon-to phosphorus bonds. Appl Microbiol Biotechnol, 1997; 48: 549-52
5. Rasol MK, Cipcic H, Hagege D: Isoesterascs related to cell differentiation in plant tissue culture. Chem-Biol Interact, 1999; 119-120: 587-92
6. Ehrich M: Using neuroblastoma cell lines to address differential specificity to organophosphates. Clin Exp Pharmacol Physiol, 1995; 22: 291-92
7. Veronesi B, Ehrich M: Different cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol Appl Pharmacol, 1993; 120: 240-46
8. Mehl A, Rolseth V, Gordon S et al: Brain hypoplasia caused by exposure to trichlorfon and dichlorvos during development can be ascribed to DNA alkylation damage and inhibition of DNA alkyltransferase repair. Neurotoxicology, 2000; 21: 165-73
9. Grzys E, Bielecki K, Sarapuk J: Aminophosphonate-induced changes of betacyanine and ionic efflux. Z. Naturforsch, 2001; 56: 349-52
10. Tsubone K: Correlation between antimicrobial activity and chelating ability of 2-(N,N,N-trialkylammonio)alkyl hydrogen phosphates. J Pharm Sci, 1991; 80: 1051-54
11. Tsubone K, Uchida N, Ito Y: Relation between structure and antimicrobial activity of 2-(N,N,N-trialkylammonio)alkyl hydrogen phosphates. J Pharm Sci, 1991; 80: 441-44
12. Zboinska E, Lejczak B, Kafarski P: Antibacterial activity of phosphono peptides based on 4-amino-4-phosphonobutyric acid. FEMS Microbiol Lett, 1993; 108: 225-30
13. Froestl W, Mickel SJ, von Sprecher G et al: Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antogonists. J Med Chem, 1995; 38: 3313-31
14. Lejczak B, Dus D, Kafarski P: Phosphonic and phosphinic acid analogues of tyrosine and 3,4-dihydroxyphenylalanine (dopa) as potential antimelanotic agents. Anticancer Drug Des, 1990; 5: 351-58
15. Fischel JL, Berlion M, Formento P et al: Evaluation of the time-schedule dependency for the cytotoxic activity of the new vinca alkaloid derivative, S 12363 (vinfosiltine), Eur J Cancer, 1993; 29A: 1890-94
16. Cherkasov RA, Galkin VI: The Kabachnik-Fields reaction: the synthetic potential and the problem of the mechanism. Russian Chemical Reviews, 1998; 67: 897-992
17. Maron DM, Ames BN: Revised methods for the Salmonella mutagenicity test. Mutat Res, 1983; 113: 174-210
18. Quillardet P, Hofnung M: The SOS-chromotest, a colorimetric bacterial assay for genotoxins: procedures. Mutat Res, 1985; 147: 65-78
19. Mersch-Sundermann V, Kern S, Winterman F: Genotoxicity of nitrated polycyclic aromatic hydrocarbons and related structures on Escherichia coli PQ37 (SOS chromotest). Environ Molec Mutagen, 1991; 18: 41-50
20. Ilinskaya O, Decker K, Koschinski A, Dreyer F: Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current. Toxicology, 2001; 156: 101-7
21. Dziamska A, Sarapuk J: Membrane-active aminophosphonates, Cell Mol Biol Lett, 2002; 7: 282
22. Kleszczynska H, Sarapuk J, Bonarska D: The hemolytic toxicity of some new aminophosphonates. Cell Mol Biol Lett, 2001; 6: 271-75
23. Sommer S, Leitao A, Bernardi A et al: Introduction of a UV-damaged replicon into a recipient cell is not sufficient condition to produce an SOS-inducing signal. Mut Res DNA Rep, 1991; 254: 107-17
24. Jiang W, Metcalf WW, Lee KS, Wanner BL: Molecular cloning, mapping, and regulation of Pho regulon genes for phosphonate breakdown by the phosphonatase pathway of Salmonella typhimurium LT2. Bacteriology, 1995; 177: 6411-21
25. Wagner ED, Marcngo MS, Plewa MJ: Modulation of the mutagenicity of heterocyclic amines by organophosphate insecticides and their metabolites. Mutat Res, 2003; 536: 103-15
26. Manetta A, Gamboa G, Nasseri A et al: Rideout, Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Gynecol Oncol, 1996; 60: 203-12
27. Trapani AJ, Bell ME, Bruseo CW et al: Pharmacological properties of CGS 35066, a potent and selective endothelin-converting enzyme inhibitor, in conscious rats. J Cardiovasc Pharmacol, 2000; 36(5 Suppl. 1): 40-43
28. Chakraborty S, Das T, Unni PR et al: 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation. Nucl Med Commun, 2002; 23: 67-74